JP2016539165A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539165A5
JP2016539165A5 JP2016536706A JP2016536706A JP2016539165A5 JP 2016539165 A5 JP2016539165 A5 JP 2016539165A5 JP 2016536706 A JP2016536706 A JP 2016536706A JP 2016536706 A JP2016536706 A JP 2016536706A JP 2016539165 A5 JP2016539165 A5 JP 2016539165A5
Authority
JP
Japan
Prior art keywords
acid
lactobionate
mpeg
ether
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016536706A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539165A (ja
JP6646578B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from US14/561,219 external-priority patent/US10835608B2/en
Publication of JP2016539165A publication Critical patent/JP2016539165A/ja
Publication of JP2016539165A5 publication Critical patent/JP2016539165A5/ja
Application granted granted Critical
Publication of JP6646578B2 publication Critical patent/JP6646578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016536706A 2013-12-05 2014-12-05 薬物転送技術のための高分子−炭水化物共役体 Active JP6646578B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361912228P 2013-12-05 2013-12-05
US61/912,228 2013-12-05
US14/561,219 2014-12-05
US14/561,219 US10835608B2 (en) 2013-12-05 2014-12-05 Polymer-carbohydrate conjugates for drug delivery technology
PCT/US2014/068798 WO2015085173A1 (en) 2013-12-05 2014-12-05 Polymer-carbohydrate conjugates for drug delivery technology

Publications (3)

Publication Number Publication Date
JP2016539165A JP2016539165A (ja) 2016-12-15
JP2016539165A5 true JP2016539165A5 (OSRAM) 2017-12-14
JP6646578B2 JP6646578B2 (ja) 2020-02-14

Family

ID=53270064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536706A Active JP6646578B2 (ja) 2013-12-05 2014-12-05 薬物転送技術のための高分子−炭水化物共役体

Country Status (6)

Country Link
US (1) US10835608B2 (OSRAM)
EP (1) EP3077006B1 (OSRAM)
JP (1) JP6646578B2 (OSRAM)
CN (2) CN113274506A (OSRAM)
CA (1) CA2932123C (OSRAM)
WO (1) WO2015085173A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201507209SA (en) 2013-03-14 2015-10-29 Univ Massachusetts Methods of inhibiting cataracts and presbyopia
WO2016209732A1 (en) 2015-06-23 2016-12-29 Wu Nian Polymer-cyclodextrin-lipid conjugates
US10064954B2 (en) 2015-06-23 2018-09-04 Nian Wu Polymer-cyclodextrin-lipid conjugates
JP6784750B2 (ja) * 2015-07-31 2020-11-11 アークトゥルス セラピューティクス, インコーポレイテッド 薬物送達のためのマルチリガンド剤
PE20181070A1 (es) 2015-11-13 2018-07-04 Univ Massachusetts Moleculas bifuncionales que contienen peg para uso en la inhibicion de cataratas y presbicia
CN108314703B (zh) 2017-01-17 2022-02-01 亚飞(上海)生物医药科技有限公司 分子定点靶向和激活的激酶抑制剂的制备和用途
CN106957421B (zh) * 2017-03-31 2018-11-20 河南大学 一种茄尼醇衍生物、制备方法及其应用
EP3661563A4 (en) 2017-07-31 2021-11-10 The Ohio State Innovation Foundation BIOMIMETIC NANOMATERIALS AND THEIR USES
WO2019143971A2 (en) * 2018-01-18 2019-07-25 Sienna Biopharmaceuticals, Inc. Formulations for dermal delivery of polymer conjugates of indolocarbazole compounds with reduced exposure
US20220016029A1 (en) * 2018-11-09 2022-01-20 Translate Bio, Inc. Multi-peg lipid compounds
PE20220902A1 (es) * 2019-06-26 2022-05-30 Biorchestra Co Ltd Nanoparticulas micelares y sus usos
CN111053741B (zh) * 2019-12-31 2021-09-28 江苏省中医院 一种用于治疗炎症性肠病的基于β-谷甾醇与5-ASA的口服多敏感胶束前药
WO2025029758A1 (en) * 2023-07-28 2025-02-06 Wu Nian Polyethylene glycol-saccharide-lipid conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309633B1 (en) * 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US7833992B2 (en) * 2001-05-18 2010-11-16 Merck Sharpe & Dohme Conjugates and compositions for cellular delivery
CN1911450A (zh) * 2006-08-21 2007-02-14 沈阳药科大学 一种含d-半乳糖和甾醇或脂肪醇的肝靶向辅料及其制剂
AP2012006053A0 (en) * 2009-06-02 2012-02-29 Brian Charles Keller Pure peg-lipid conjugates.
CN101831067A (zh) * 2010-05-31 2010-09-15 王二新 聚乙二醇脂类缀合物及其在制备药物中的应用
US20120202890A1 (en) * 2011-02-08 2012-08-09 Nian Wu Polymer-carbohydrate-lipid conjugates
WO2012122144A1 (en) * 2011-03-07 2012-09-13 Wu Nian Highly monodisperse branched peg-lipid conjugates
US8883177B2 (en) * 2011-06-28 2014-11-11 Nian Wu Pharmaceutical compositions for parenteral administration

Similar Documents

Publication Publication Date Title
JP2016539165A5 (OSRAM)
JP2018521152A5 (OSRAM)
EP3077006B1 (en) Polymer-carbohydrate conjugates for drug delivery technology
JP2011525514A5 (OSRAM)
Menger et al. Gemini surfactants with a disaccharide spacer
Mitra et al. Cholesterol solubilization in aqueous micellar solutions of quillaja saponin, bile salts, or nonionic surfactants
ES2616011T3 (es) Composición de emulsión de aceite en agua
JP2018521152A (ja) 高分子−シクロデキストリン−脂質共役体
JPWO2021086833A5 (OSRAM)
HRP20160816T1 (hr) Upotreba virusa influence i emulzije ulja u vodi kao adjuvansa radi poticanja t-stanica cd4 i/ili poboljšanog odgovora memorijskih b-stanica
JP2015519330A5 (OSRAM)
HRP20170433T1 (hr) Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci
JP2006500437A5 (OSRAM)
AR094936A1 (es) Suspensión para administración oral que comprende tolvaptán amorfo, y a un método para producirla
JP2016531895A5 (OSRAM)
JP2014501730A5 (OSRAM)
RU2013112807A (ru) Композиция для доставки активных агентов в желудок
JP2013522231A5 (OSRAM)
JP2021130693A (ja) 経皮吸収製剤
WO2010087032A1 (ja) 口腔内フィルム状基剤及び製剤
WO2016086011A1 (en) Neat liquid pharmaceutical formulations
EP3861999A1 (en) Asenapine-containing adhesive patch
ES2574825T3 (es) Análogos de glicolípidos útiles como inmunoadyuvantes
JP2019131504A (ja) カプセル及びその製造方法、並びにカプセル入り化粧料及びその製造方法
JP2013227296A5 (OSRAM)